Brain Tumor Stem Cells
Brain Tumor Stem Cells - Related Videos
09:36
Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
0 Views •
Cited by 11 •
2018
Here, we describe live-cell imaging techniques to quantitatively measure the migration and invasion of glioblastoma brain tumor stem cells over time and under multiple treatment conditions.
08:14
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
0 Views •
Cited by 21 •
2012
The identification of brain tumor initiating cells (BTICs), the rare cells within a heterogeneous tumor possessing stem cell properties, provides new insights into human brain tumor pathogenesis. We have refined specific culture conditions to enrich for BTICs, and we routinely use flow cytometry to further enrich these populations. Self-renewal assays and transcript analysis by single cell RT-PCR can subsequently be performed on these isolated cells.
03:14
PDAC Stem Cell Isolation: A Method to Isolate Cancer Stem Cells from Pancreatic Tumors
0 Views •
2023
This article describes the technique for isolating pancreatic cancer stem cells (CSCs) from human pancreatic ductal adenocarcinoma (PDAC) tissue. These CSCs are used to study the functional effects of drug treatment on the in vitro self-renewal capacity of CSCs for developing more efficient cancer treatments.
03:33
Intranasal Delivery of Therapeutic Neural Stem Cells (NSCs) in Murine Model: A Procedure for Tumor-targeted Delivery of Oncolytic Virus Loaded NSCs into Brain Tumor Bearing Mouse Model
0 Views •
2025
This video demonstrates the intranasal delivery of oncolytic virus loaded therapeutic neural stem cells into a brain-tumor bearing mouse model. The non-invasive intranasal administration of stem cells bypasses the blood brain barrier, facilitating their delivery to the tumor site in the brain for therapeutic applications.
06:59
Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model
0 Views •
Cited by 35 •
2012
The generation and characterization of tumor specific T cells using humanized mice is described here. Human thymic tissue and genetically modified human hematopoietic stem cells are transplanted into immunocompromised mice. This results in the reconstitution of an engineered human immune system allowing for in vivo examination of anti-tumor immune responses.
FAQs
Asymmetric division lets a brain tumor stem cell preserve a stem-like population while producing progeny with different cancer-cell characteristics. This dual outcome supports continued tumor growth and helps generate cellular diversity within a tumor. Consequently, examining division patterns can connect the persistence of these cells with tumor maintenance rather than treating all tumor cells as biologically equivalent.
Signals from the surrounding microenvironment can alter how brain tumor stem cells behave and remain viable within a tumor. This adaptability means the local niche is not merely background tissue; it can support stem-cell maintenance and influence tumor growth. Studying these interactions therefore broadens therapeutic reasoning from the tumor cells alone to the conditions that sustain them.
Their capacity to adapt to a changing tumor context and continue generating diverse progeny helps explain why treatment may fail to eliminate the disease completely. If the stem-cell population persists, it can contribute to renewed tumor growth after therapy. This connection makes recurrence and treatment failure important outcomes when evaluating strategies directed at brain tumors.
Analysis can center on three linked features: whether the cells maintain self-renewal, how they divide asymmetrically, and what kinds of progeny they generate. Researchers can then relate these properties to tumor growth, heterogeneity, and therapy resistance. This framework connects cellular behavior with clinically relevant questions about how tumors begin, persist, and return after treatment.
Because their properties are associated with tumor initiation, recurrence, heterogeneity, and treatment failure, these cells provide biologically relevant features for investigation as biomarkers. Characterizing such features may help distinguish clinically meaningful tumor behavior and support more individualized treatment decisions. Their study therefore links cellular research with efforts to develop personalized medicine for brain tumors.
Brain tumor stem cells can respond to signals from their surrounding microenvironment, while the niche can support their maintenance. A treatment strategy that considers both components addresses the cellular population and the conditions that help sustain it. This combined focus is relevant to developing approaches aimed at limiting tumor growth, recurrence, and resistance more comprehensively.